References
- Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, Fukunaga Y, Yamamoto M. Antinuclear antibodies in children with chronic nonspecific complaints. Autoimmunity. 1997; 25243–2501.
- Itoh Y, Fukunaga Y, Igarashi T, Imai T, Yoshida J, Tsuchiya M, Fujino O, Murakami M, Yamamoto M. Autoimmunity in chronic fatigue syndrome in children. Jpn J Rheumatol. 1998; 8429–437.
- Itoh Y, Igarashi T, Tatsuma N, Imai T, Yoshida J, Tsuchiya M, . Immunogenetic background of patients with autoimmune fatigue syndrome. Autoimmunity. 2000; 32193–197.
- Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shokawa Y, . HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol. 1985; 12919–923.
- Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM. Autoantibodies to DFS 70 kDa/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol. 2000; 101211–1220.
- Ge H, Si Y, Roeder RG. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 1998; 176723–6729.
- Singh DP, Ohguro N, Chylack LTJr, Shinohara T. Lens epithelium-derived growth factor: Increased resistance to thermal and oxidative stresses. Invest Ophthalmol Vis Sci. 1999; 401444–1451.
- Ge H, Si Y, Roeder RG. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 1998; 176723–6729.
- Itoh Y, Rader MD, Reichlin M. Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: Evidence for 4 antigenically distinct forms. Clin Exp Immunol. 1990; 8145–51.
- Itoh Y, Itoh K, Frank M, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent II: Antibodies to the denatured form of 52 kDa Ro/SSA are cross reacting subset of antibodies to the native 60 kDa Ro/SSA molecule. Autoimmunity. 1992; 1489–96.
- Itoh Y, Imai T, Fujino O, Fukunaga Y. Subclinical Sjögren's syndrome and anti-Ro/SSA positive autoimmune fatigue syndrome in children. Modern Rheumatol. 2002; 12201–205.
- Maertens G, Cherepanov P, Pluymers W, Busschots K, DeClercq E, Debyser Z, Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem. 2003; 27833528–33539.
- Ganapathy V, Daniels T, Casiano CA. LEDGF/p75: A novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun Rev. 2003; 2290–297.